CAS 380620-88-2 MFCD03791318-[(PF)PHE4]NOCICEPTIN(1-13)NH2 TAO{mole}

[(PF)PHE4]NOCICEPTIN(1-13)NH2

CAS 380620-88-2 MFCD03791318

化学结构图

SMILES: C[C@@H](O)[C@H](NC(=O)[C@H](CC1C(F)=C(F)C(F)=C(F)C=1F)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1C=CC=CC=1)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(N)=O

化学属性

Mol. Formula	C61H95F5N22O15
Mol. Weight	1471.55

别名和识别编码

Chemical Name	[(PF)PHE4]NOCICEPTIN(1-13)NH2

信息真实价格透明资金保障专业采购外包团队在线服务

品牌质保精细包装现货库存一流品牌服务

相关文献及参考

[2]. Bigoni R, et al. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies. Naunyn Schmiedebergs Arch Pharmacol. 2002;365(6):442-449.
[3]. Guerrini R, et al. Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH(2): identification of highly potent agonists of the nociceptin/orphanin FQ receptor. J Med Chem. 2001;44(23):3956-3964.
[1]. Rizzi A, et al. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies. Naunyn Schmiedebergs Arch Pharmacol. 2002;365(6):450-456.
[1]. Rizzi A, et al. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)NH2 analogues. 2. In vivo studies. Naunyn Schmiedebergs Arch Pharmacol. 2002;365(6):450-456.
[2]. Bigoni R, et al. Pharmacological characterisation of [(pX)Phe4]nociceptin(1-13)amide analogues. 1. In vitro studies. Naunyn Schmiedebergs Arch Pharmacol. 2002;365(6):442-449.
[3]. Guerrini R, et a